YKL-40 antagonists (Molecure)

N/A

Report date: 2025/03/20 09:21:17
NME

Base Information

Drug NameYKL-40 antagonists (Molecure)
Drug Alias NameYKL-40 antagonists (OncoArendi Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChitinase-3-like protein 1 inhibitors
TargetsChitinase-3-like protein 1
Therapy Area/IndicationsInflammationGlioblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMolecure SA
China Registration ClassN/A

Develop Information

Active CompaniesMolecure SA
Inactive CompaniesN/A
Active IndicationsInflammationGlioblastoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A